Comments
Shares of Orchid Pharma on Friday hit a 52-week high of ₹435.45 apiece on NSE after the company reported a turnaround in its financial performance.
The Chennai-based company recorded a net profit of ₹55.24 crore for 2022-23 against a net loss of ₹56.89 crore for 2021-22. The company’s share on the NSE hit the 5 per cent upper circuit for a second day in row.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.